Get started
ADVANCED ENZYME TECHNOLOGIES LADVANCED ENZYME TECHNOLOGIES LADVANCED ENZYME TECHNOLOGIES L

ADVANCED ENZYME TECHNOLOGIES L

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

ADVENZYMES trade ideas

ADVENZYMES..NSE:ADVENZYMES Please note that we are not a SEBI Registered Investor Adviser/PMS/ Broking House. All the contents over here are for educational purposes only and are not investment advice or recommendations offered to any person(s) with respect to the purchase or sale of the stocks / futures and options. You are also requested to apply your prudence and consult your advisers in case you choose to act on any such content available as WE claims no responsibilities for any of your actions or any outcome of such action
NSE:ADVENZYMESShort
by TrAder_3101_
ADVENZYMES..NSE:ADVENZYMES Please note that we are not a SEBI Registered Investor Adviser/PMS/ Broking House. All the contents over here are for educational purposes only and are not investment advice or recommendations offered to any person(s) with respect to the purchase or sale of the stocks / futures and options. You are also requested to apply your prudence and consult your advisers in case you choose to act on any such content available as WE claims no responsibilities for any of your actions or any outcome of such action
NSE:ADVENZYMES
by TrAder_3101_
advanced anzymincorporated by second generation enzymologists, the Rathi brothers in 1989, Advanced Enzyme Technologies (AET) is one of the largest research driven Indian enzyme companies with a product basket of 400+ proprietary products developed from 68 indigenous enzymes and probiotics. Broadly, the business can be divided into three segments - 1) human healthcare, 2) animal healthcare and 3) industrial processing. It manufactures enzymes by using natural resources such as plants, fungal, bacterial and animal sources, using environment-friendly biotechnology processes. It offers these products to 700+ customers across 45 countries worldwide The company reported growth in sales/ebitda/pat in Q4FY21 on a YoY basis. The revenue bifurcation of the company- Human HC (73%), Animal HC (12%) and Industrial processing (15%). Globally, growth of the enzymes market piggybacks on a diverse spectrum of customer base. This, together with limited number of meaningful players, has created a conducive business environment for existing players in the space. One of the biggest challenges facing new companies looking to enter the enzyme industry is to offer continuous and differentiated solutions as per the client’s requirement that demands real time R&D capability and flexibility in manufacturing. Large manufacturing capacities, proven capabilities, experienced promoters, customer stickiness, fairly consistent track record, ability to develop new products in-house and quest for unique acquisitions are some differentiators for Advanced enzymes. The company is poised to capture the growing opportunities in the enzymes and probiotics space backed by proven capabilities and stable financials that have been fairly consistent, thanks to a mix of organic and inorganic growth strategy employed by the management. Strong margins and healthy return ratios reflect the pricing power and balance sheet strength of the company. Going ahead, the management intends to augment its R&D capability for better facilitation and strengthening of in-house R&D capability, which bodes well in the long run.
NSE:ADVENZYMESLong
by Tradernawab
ADVANCED ENZYMES: Bullish View ready to march aheadADVANCED ENZYMES stock has been consistently performing well irrespective of the overall market and now the stock has given a major breakout from it's previous highs. Invest in the stock for next 4-5 months for good move. The 1st target for the stock will be 550 (20% up) and 2nd target for the stock will be 570 (25% up). Keep initial stop loss of 400 and buy. **ideas are my own***Invest as per your risk taking appetite**
NSE:ADVENZYMESLong
by vivek3032810101